-3 2x1.jpg)
A message from Curtiss-Wright
High-Temperature neutron flux detectors for Generation IV reactors and SMRs
SHINE Technologies, the Janesville, Wis.–based producer of medical radioisotopes, announced that it has submitted a drug master file (DMF) with the U.S. Food and Drug Administration for non-carrier-added (n.c.a.) lutetium-177 chloride, a radiopharmaceutical used for the treatment of cancer.
ANSTO-designed target increases Mo-99 yield
The Australian Nuclear Science and Technology Organization (ANSTO) announced that it has made progress on a more cost-effective way to produce the medical radioisotope molybdenum-99, with less...
Westinghouse teams with Nordion and PSEG to produce Co-60 at Salem
Westinghouse Electric Company, Nordion, and PSEG Nuclear announced on Tuesday the signing of long-term agreements to establish the first commercial-scale production of cobalt-60 in a U.S....
Co-60 tariffs would undermine U.S. health care, SSWG warns
In a letter to the Office of the U.S. Trade Representative, the Source Security Working Group (SSWG) is urging the U.S. government to withhold from imposing tariffs on Canadian-orgin cobalt-60...
Clarity and Nusano agree on medical isotopes deal
Australia-based Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company, has signed a supply agreement for copper-67 with Nusano, Inc., headquartered in California. Nusano...
Orano to supply Zeno with Am-241 to power space missions
Zeno Power, a developer of nuclear batteries, is to receive americium-241 recovered from Orano’s La Hague nuclear fuel recycling site in Normandy, France, under a strategic agreement...
The value of recycled U and Pu brings Standard Nuclear and Shine together
Shine Technologies has been developing fusion-adjacent technologies in Janesville, Wis., including nuclear fuel recycling, since its founding in 2005. Standard Nuclear of Oak Ridge, Tenn., was...
Argonne to work with Shine on cost-effective recycling technology
The Department of Energy’s Argonne National Laboratory will collaborate with Wisconsin-based fusion technology company Shine to design new chemical processes for separating valuable...
Orano Med expands its Texas Pb-212 R&D center
Orano Group subsidiary Orano Med, a developer of targeted alpha therapies for oncology, inaugurated the expansion of its main research and development center located in Plano, Texas. The...
ANS holds Educator Training webinar on nuclear waste
A recent American Nuclear Society webinar tackled misconceptions about nuclear waste. Christopher Perfetti, an associate professor of nuclear engineering at the University of New Mexico,...
SHINE to acquire Lantheus’s SPECT business line
SHINE Technologies, a fusion company building what is set to be the world’s largest medical isotope production facility at its Wisconsin campus, announced that it has agreed to acquire the...